Home/Filings/4/0001209191-22-010071
4//SEC Filing

Becker Marc A. 4

Accession 0001209191-22-010071

CIK 0001367920other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 8:00 AM ET

Size

5.4 KB

Accession

0001209191-22-010071

Insider Transaction Report

Form 4
Period: 2022-02-14
Transactions
  • Sale

    Common Stock

    2022-02-14$3.08/sh3,762$11,587139,011 total
Footnotes (3)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $3.01 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Issuer

CONCERT PHARMACEUTICALS, INC.

CIK 0001367920

Entity typeother

Related Parties

1
  • filerCIK 0001618060

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:00 AM ET
Size
5.4 KB